Research-Ready FFPE Tissue Samples with Verified Clinical Annotation
MT Group has supplied FFPE biospecimens for over 20 years. Every block we provide undergoes review by our board-certified pathologists in addition to the pathology review conducted by our collection sites. Our clinical data team verifies that annotations are complete and internally consistent and confirms that pathology matches the stated diagnosis. This dual-layer review process addresses the quality issues that have become more common in the FFPE market in recent years.
Research-Ready FFPE Tissue Samples with Verified Clinical Annotation
MT Group has supplied FFPE biospecimens for over 20 years. Every block we provide undergoes review by our board-certified pathologists in addition to the pathology review conducted by our collection sites. Our clinical data team verifies that annotations are complete and internally consistent and confirms that pathology matches the stated diagnosis. This dual-layer review process addresses the quality issues that have become more common in the FFPE market in recent years.
Trusted Source for FFPE Tissue Blocks and Sections
FFPE tissue blocks are essential tools in pharmaceutical research and biomarker development, enabling retrospective studies with preserved tissue architecture and the ability to perform immunohistochemistry, in situ hybridization, and increasingly, genomic analyses.
MT Group maintains two levels of inventory to meet research timelines and needs. Our onsite biobank provides immediate access to FFPE blocks in cancer as well as select autoimmune and metabolic diseases.
Many of these onsite specimens include matched normal adjacent tissue FFPE as well as plasma and buffy coat. Our virtual biobank network extends access although with somewhat longer fulfillment times. MT Group can provide whole blocks or cut slides depending on protocol requirements and maintains a detailed output sheet specifying available samples.
Why Leading Researchers
Choose MT Group FFPE Samples
Poor quality FFPE samples force repeated experiments and delay research timelines. For pharmaceutical development, where biomarker validation and target identification depend on accurate tissue analysis, these quality failures can add months or years to timelines — garbage in, garbage out.
MT Group pathologists confirm diagnoses and evaluate blocks for tumor cell content, tumor stroma content, necrosis, tissue size, fixation quality, and block integrity. The clinical data team verifies that all annotations are complete and internally consistent. The business development team works with researchers to clarify project requirements and identify appropriate samples, either selecting cases based on customer specifications or providing output sheets for customer selection.
All told, MT Group’s quality control measures and consultative approach are more resource-intensive but ultimately enhance research results.
Quality Assurance & Services
Ethical procurement, rigorous reviews and full traceability ensure specimens you can trust.
IRB‑Approved Collections
All MT Group tissue collections are conducted under Institutional Review Board (IRB) approval, ensuring ethical procurement and full regulatory compliance. This commitment guarantees that every specimen is collected with proper informed consent and adheres to the highest standards of human subject research protections.
Dual Pathologist Review
Every FFPE tissue block is reviewed by a pathologist at the collection site prior to shipment and MT Group's board-certified pathologists independently confirm the site's pathology review and diagnosis. This multi-level review process ensures diagnostic accuracy, verifies adequate tissue quality and quantity, and provides confidence that specimens meet the precise disease criteria required for your research.
Specimen Replacement Guarantee
MT Group stands behind the quality of every specimen delivered. If any tissue fails to meet specifications due to shipping issues, handling concerns, or quality parameters, we will replace the specimen at no additional cost, ensuring your research timelines and budgets remain on track.
Chain of Custody & Documentation
Comprehensive documentation accompanies each specimen, including collection details, processing protocols, storage conditions, and pathology reports. This complete chain of custody provides full traceability and the clinical context necessary for robust, reproducible research outcomes.
Why Leading Researchers Choose MT Group
Frequently Asked Questions
How long does it take to receive FFPE blocks?
Delivery timelines depend on whether blocks are in MT Group's onsite inventory or at one of our collection sites. Onsite blocks that have completed quality control are typically ready to ship within 1-2 weeks. Onsite blocks that require additional data QC before release take approximately 2-4 weeks. Blocks from MT Group's virtual biobank network require shipping to MT Group for pathologist review and data QC, which can extend the timeline somewhat. MT Group’s business development team will provide a specific timeline for each project based on sample availability and QC status.
Are matched normal adjacent tissue (NAT) FFPE, plasma and buffy coat available with FFPE blocks?
Yes, matched NAT and biofluids such as plasma and buffy coat are often available. This enables comprehensive multi-omics studies and correlative analyses between tissue-based findings and circulating biomarkers. Availability of matched samples for banked specimens depends on what was collected at the time of the original procedure while prospective collections can be designed to include any combination of tissue and biofluids.
What are "waiver of consent" biospecimens?
Waiver of consent biospecimens are residual clinical samples collected under an IRB-approved protocol that waives the requirement for individual patient informed consent for the sample’s use in research. These specimens are typically leftover tissue from surgical or diagnostic procedures that would otherwise be discarded. The same research uses are permitted under IRB waiver of consent as are with fully consented cases.
Is matched frozen tissue available with FFPE blocks?
Matched frozen tissue is not available in MT Group's onsite inventory. However, some collection sites within the virtual biobank network may have archived frozen tissue matched to FFPE blocks. For projects requiring matched frozen and FFPE specimens, prospective collection is also an option. The business development team can assess availability based on specific disease type and sample requirements.
Contact MT Group
Complete the form below to discuss your tissue requirements with our experts.
No obligation consultation. Response within one business day.
